Back
WuXi Biologics (Cayman) 10K Form
Sell
10
WXIBF
WuXi Biologics (Cayman)
Last Price:
1.65
Seasonality Move:
12.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive WXIBF News And Ratings
See the #1 stock for the next 7 days that we like better than WXIBF
WXIBF Financial Statistics
Sales & Book Value
| Annual Sales: | $2.41B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.34 |
| Price / Book: | 1.24 |
Profitability
| EPS (TTM): | 0.10890 |
|---|---|
| Net Income (TTM): | $480.83M |
| Gross Margin: | $965.27M |
| Return on Equity: | 8.57% |
| Return on Assets: | 6.45% |
WuXi Biologics (Cayman) Earnings Forecast
Key WuXi Biologics (Cayman) Financial Ratios
- The Gross Profit Margin over the past 10 years for WXIBF is 40.08%.
- The Selling, General & Administrative Expenses for WXIBF have been equal to 10.50% of Gross Profit Margin.
- The Research & Development expenses have been 4.61% of Revenue.
- The Interest Expense is 4.66% of Operating Income.
- The Net Earning history of WXIBF is 19.96% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 8 years.
WuXi Biologics (Cayman) Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | WXIBF |
| Website: | wuxibiologics.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 2.78 |
| Quick Ratio: | 2.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 15.57 |
|---|---|
| Forward P/E Ratio: | 0 |
WXIBF Technical Analysis vs Fundamental Analysis
Sell
10
WuXi Biologics (Cayman) (WXIBF)
is a Sell
Is WuXi Biologics (Cayman) a Buy or a Sell?
-
WuXi Biologics (Cayman) stock is rated a Sell
The current WuXi Biologics (Cayman) [WXIBF] share price is $1.65. The Score for WXIBF is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.